2-(2-Cyanoethylamino)-2-methylpropanoic acid, 95.0%, 2g

Tert-butyl (2S,4S)-4-amino-2-(hydroxymethyl)piperidine-1-carboxylate, 97%, 250mg

6-Chlorobenzo[d]thiazole-2-thiol, 95.0%, 1g

(3-Vinylphenyl)boronic acid, 95.0%, 5g

tert-Butyl 1H-pyrrole-3-carboxylate, 98%, 500mg

Syringic acid, 97.0%, 100g

3-Amino-2,5-dichloropyridine, 98.0%, 25g

Niobium tube 99.9% 8.0 mm diameter, 0.4 mm wall thickness 0,5 m

GC capillary column ROTI®Cap-5 MS Ultra, 12 m, 0.20 mm, 0.35 µm, 1 Piece(s)

4-Methyl-2-(piperidin-4-yloxy)pyrimidinehydrochloride, 1g

(2-Amino-5-bromophenyl)dimethylphosphine oxide, 98%, 5g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2,5-difluorophenyl)propanoic acid, 98%, 100mg

tert-Butyl 4-(4-Bromophenyl)piperazine-1-carboxylate>98.0%(T)1g